Given the number of times this has happened already, it should come as little surprise that we’re now faced with yet another ...

The rapid identification of respiratory virus outbreaks is needed to enable rational and effective public health interventions. We developed new quantitative approaches for simultaneous ...

When the first reports of a new COVID-19 variant emerge, scientists worldwide scramble to answer a critical question: Will ...

The COVID pandemic illustrated how urgently we need antiviral medications capable of treating coronavirus infections. To aid ...

After more than three years of intensive investigation, the World Health Organization’s (WHO) Scientific Advisory Group for the Origins of Novel Pathogens (SAGO) has released its long-anticipated ...

The World Health Organization's probe into the cause of COVID-19 has not resulted in a definitive reason, with its director-general saying all scenarios 'remain on the table.' ...

The human body is naturally equipped with defenses to fight off viral infections. For a virus to successfully infect it, it must first overcome these defenses. To do so, viruses have evolved ...

Using a hamster model, the research compared infection with the original SARS-CoV-2 virus from 2020 to several subsequent variants including Gamma, Delta and Omicron/BA.1 variants.

Using the HNO model, the team of researchers showed key differences between the infection caused by SARS-CoV-2 and that of RSV, a major pediatric respiratory virus.

A COVID-19 vaccine, created from a virus-like nanoparticle that displays SARS-CoV-2 spike protein RBDs, effectively protects animal model from infection.